Alnylam Pharmaceuticals
ALNY
#585
Rank
C$47.02 B
Marketcap
$366.32
Share price
1.81%
Change (1 day)
46.29%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) Fails to deliver data

Key failure to deliver metrics for Alnylam Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Alnylam Pharmaceuticals (ALNY) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Alnylam Pharmaceuticals (ALNY) - since 2013

Volume in USD (price x number of shares), data since 2013

Alnylam Pharmaceuticals (ALNY) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024C$28.62 M-44.95%
2023C$51.99 M-66.55%
2022C$0.15 B200.46%
2021C$51.74 M-9.83%
2020C$57.38 M52.34%
2019C$37.66 M46.52%
2018C$25.7 M-70.97%
2017C$88.54 M191.96%
2016C$30.32 M-14.94%
2015C$35.65 M68.07%
2014C$21.21 M152.1%
2013C$8.41 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
C$1.57 MC$10.39 M๐Ÿ‡บ๐Ÿ‡ธ USA
C$8.36 MC$0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA
C$22.99 MC$39.93 M๐Ÿ‡บ๐Ÿ‡ธ USA
C$11.72 MC$60.14 M๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.38 MC$5.65 M๐Ÿ‡บ๐Ÿ‡ธ USA
C$23.37 MC$86.57 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$3.41 MC$70.14 M๐Ÿ‡ซ๐Ÿ‡ท France
C$5.83 MC$29.52 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel